bioRxiv · 10.1101/2020.12.10.419747
Epilepsy kinase CDKL5 is a DNA damage sensor which controls transcriptional activity at DNA breaks
Abstract
Mutation of the CDKL5 kinase gene leads to the seizure-prone neurodevelopmental condition CDD (CDKL5 deficiency disorder) and is the most common genetic cause of childhood epilepsy. However, the phospho-targets and roles of CDKL5 are poorly understood, especially in the nucleus. We reveal CDKL5 as a sensor of DNA damage in actively transcribed regions of the nucleus, which phosphorylates transcriptional regulators such as Elongin A (ELOA) on a specific consensus motif. Recruitment of CDKL5 and ELOA to DNA damage sites, and subsequent ELOA phosphorylation, requires both active transcription and synthesis of poly-ADP ribose to which CDKL5 can bind. Critically, CDKL5 is essential for transcriptional control at DNA breaks. Therefore, CDKL5 is a DNA damage-sensing regulator of transcription, with implications for CDKL5-related human diseases. One sentence summaryCDKL5 is a DNA damage-sensing kinase that modulates transcriptional activity near DNA breaks.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Khanam, T., Munoz, I., Weiland, F., Carroll, T., Borsos, B., Pantazi, V., Slean, M., Novak, M., Toth, R., Appleton, P., Pankotai, T., Zhou, H., Rouse, J.. 2020-12-11. Epilepsy kinase CDKL5 is a DNA damage sensor which controls transcriptional activity at DNA breaks. https://doi.org/10.1101/2020.12.10.419747
Cite the original work for its findings. Save a collection to share your selection of sources.